Home >   Products   >  Advanced Search

(CAS RN:77191-36-7 Product Number:N0996)


Synonym N-(2,6-Dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide

General Information

Product Number N0996

* Items available from stock in Japan will be delivered in 10 business days.
* Please contact us if you need further information.
(Sales Dept Tel: +32 (0)3 735 07 00 E-mail: Sales-EU@TCIchemicals.com)
* To send your quote request for bulk quantities, please click on the “Request Bulk Quotation” button. Please note that for some of our products we cannot offer bulk quantities.
* TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.

Purity/Analysis Method >98.0%(N)
Storage Temperature
M.F. / M.W. C14H18N2O2=246.31
CAS RN 77191-36-7
Related CAS RN
MDL Number MFCD00209882
Packaging and Container
  • Product Details
  • Safety & Regulations


Purity(HPLC) min. 95.0 area%
Purity(with Total Nitrogen) min. 98.0 %
Melting point 149.0 to 153.0 deg-C


Reaxys-RN 6848330
PubChem SID 253660872
Merck Index(14) 6439
RTECS# UX9655650


Signal Word Warning
Hazard Statements
  • H302
  • :Harmful if swallowed.
  • H361fd
  • :Suspected of damaging fertility. Suspected of damaging the unborn child.
Precautionary Statements
  • P201
  • :Obtain special instructions before use.
  • P264
  • :Wash hands and face thoroughly after handling.
  • P270
  • :Do not eat, drink or smoke when using this product.
  • P280
  • :Wear protective gloves, protective clothing, face protection.
  • P308+P313
  • :IF exposed or concerned: Get medical advice or attention.
  • P405
  • :Store locked up.

Transport Information

HS Number 2933790090


Nefiracetam: A Pyrrolidone Nootropic Agent

Nefiracetam (DM-9384) is a pyrrolidone nootropic agent being developed for the treatment of Alzheimer's type and poststroke vascular-type dementia. It has shown the ability to increase the activity of choline acetyltransferase in the hippocampus of animals. In addition, nefiracetam enhances the activity of neuronal L-type calcium channels under the regulation of inhibitory G-proteins and cyclic AMP-dependent processes. (The product is for research purpose only.)


PubMed Literature

Page Top